Document:

EX 101

		

			

		

		
			Exhibit 10.1
		

		
			September 21,  2016
		

		
			﻿
		

		
			﻿
		

		
			Mr. Jeffrey M. Farber
		

		
			﻿
		

		
			Dear Jeff:
		

		
			﻿
		

		
			I am pleased to confirm the details of our offer of employment to join The Hanover Insurance Group, Inc. (the “Company” or  “The Hanover”). As we discussed, you will join The Hanover on or about October 1, 2016, initially with the title Executive Vice President - Senior Finance Officer, reporting to Mr. Joseph M. Zubretsky, President and Chief Executive Officer of The Hanover. You will have such duties and responsibilities as shall be assigned to you by Mr. Zubretsky. Our expectation is that Mr. Eugene Bullis will continue as Chief Financial Officer until on or about November 4, 2016. Upon the execution and subsequent filing of the Company’s third quarter Form 10-Q with the Securities and Exchange Commission, you will assume the responsibilities and title of Chief Financial Officer. The material terms and conditions of this offer letter are contingent upon approval from the Board of Directors.  The offer is also contingent upon a satisfactory reference and background check. The terms of your employment are as follows: 
		

		
			﻿
		

			
	
			
				 1.
			

			
	
			
			Base Salary: Effective on the date you commence employment with The Hanover (your “Employment Date”), your salary will be payable in biweekly installments which annualize to $650,000.  

		
			﻿
		

			
	
			
				 2.
			

			
	
			
			Short-Term Incentive Compensation (“STIC”):  

		
			﻿
		

		
			2016 STIC Award
		

		
			You will participate in a tailored 2016 STIC program in accordance with the terms of the plan attached hereto as Exhibit A.
		

		
			﻿
		

		
			Eligibility for 2017 STIC Award
		

		
			Your 2017 STIC target award, for which you will be eligible next year, will equal 100% of your base salary.  Actual payouts, however, may range from 0% to 200% of target depending upon your individual performance and The Hanover’s performance against certain pre-established performance criteria approved by the Compensation Committee of the Board of Directors (the “Compensation Committee”). 
		

		
			﻿
		

		
			Terms and Conditions
		

		
			The terms and conditions of our annual STIC programs are established by the Compensation Committee typically at the regularly scheduled February meeting.  Any STIC payment, including the 2016 STIC award, is contingent upon you being employed at The Hanover at the time the payment is made and is subject to the terms and conditions of the program.
		

		

		

		 

		

			 

		

 

		

			 

		

		

			Jeffrey M. Farber

		

		

			September 21, 2016

		

		

			Page 2 of 8

		

		

			 

		

		﻿
		

			
	
			
				 3.
			

			
	
			
			Long-Term Incentive Compensation (“LTIC”): 

		
			﻿
		

		
			Sign-On LTIC Award
		

		
			Effective on October 3, 2016, you will receive a one-time sign-on long-term equity incentive award with an estimated grant date fair value of approximately $900,000 (the “Sign-On Award”).  Approximately one-half of the value of the Sign-On Award will be in the form of performance-based restricted stock units (“PBRSUs”) that will vest, if at all, at a level commensurate with the achievement of the performance metric summarized below, on the third anniversary of the grant date.  Actual payouts may range from 0% to 150% of the targeted number of units based upon The Hanover’s relative total shareholder return measured from the grant date through December 31, 2018.  The balance of your Sign-On Award will be granted in the form of stock options (i) having an exercise price equal to the closing price of the Company’s common stock on October 3, 2016, and (ii) that will vest in three approximately equal annual installments commencing on the first anniversary of the grant date.
		

		
			﻿
		

		
			2017 LTIC Award
		

		
			For fiscal year 2017, we anticipate that your LTIC equity award will have an estimated grant date fair value of approximately $1,200,000 (the “2017 Award”).  The actual amount, mix, terms and timing of such award will, however, be determined by the Compensation Committee. 
		

		
			﻿
		

		
			The grant of any of the foregoing equity LTIC awards shall be subject to (i) approval by the Compensation Committee; (ii) the terms of The Hanover Insurance Group 2014 Long-Term Incentive Plan; and (iii) the applicable grant agreements.
		

		
			﻿
		

		
			Retirement: Notwithstanding the foregoing, your 2017 Award, Sign-On Award and any future long-term equity awards will provide for pro-rated vesting of restricted stock units upon Retirement. Additionally, upon Retirement, any then vested stock options shall remain exercisable for a period of three (3) years (but in no event later than the option’s scheduled expiration date). The term “Retirement” as used in herein only, shall have the meaning set forth in the Company’s standard option grant agreement as determined by the Compensation Committee from time to time. 
		

		
			﻿
		

			
	
			
				 4.
			

			
	
			
			Annual Compensation Review: It is the practice of the Compensation Committee to review, and adjust, if deemed appropriate, the total compensation paid to the Company’s executive officers annually, typically at its regularly scheduled February meeting.  Given the timing of your initial compensation determination, it is not expected that your compensation package will be adjusted until 2018. 

		

		

		 

 

		

			 

		

		

			Jeffrey M. Farber

		

		

			September 21, 2016

		

		

			Page 3 of 8

		

		

			 

		

		
		

			
	
			
				 5.
			

			
	
			
			Relocation: You will be eligible to receive relocation assistance during the first twenty-four months of your employment under The Hanover Insurance Group Executive Relocation Program.  If you voluntarily terminate your employment without “Good Reason” (as defined below), or your employment is terminated by The Hanover for “Cause” (as defined in the Change in Control Plan), within twenty-four (24) months from the start of your relocation process (the “Measurement Period”),  then you will be obligated to repay the unearned portion of such relocation expenses.  The start of the Measurement Period is the date of the first incurred expense by the relocation vendor.   The “unearned portion of such relocation expenses” shall be calculated by subtracting the number of whole months during the Measurement Period you worked from 24, and dividing the resulting difference by 24, and then multiplying the resulting quotient by the total amount of such relocation expenses.

		
			﻿
		

			
	
			
				 6.
			

			
	
			
			Benefits: You will be eligible to participate in The Hanover’s benefit programs, including, but not limited to, Group Medical, Dental, Life, Short and Long-Term Disability Insurance, The Hanover Insurance Group Retirement Savings Plan, and our Non-Qualified Retirement Savings Plan.  Eligibility for and entitlements to benefits are determined by the terms and conditions of the applicable benefit plans, as they may be amended from time to time.  

		
			﻿
		

		
			You will be eligible to earn four (4) weeks of vacation annually.  
		

		
			﻿
		

		
			You will be eligible to participate in the financial planning and matching gifts programs currently available to other senior executives. 
		

		
			﻿
		

			
	
			
				 7.
			

			
	
			
			Severance Protection:  

		
			﻿
		

		
			Change in Control
		

		
			You will be eligible to participate in The Hanover Insurance Group, Inc. Amended and Restated Employment Continuity Plan (the “Change in Control Plan”), in accordance with the terms thereof, as an “Executive Tier Participant” with a 2X “Multiplier” but without a Section 280G excise tax “gross up” and on a “best net” basis instead.  Participation in the Change in Control Plan requires agreement to certain non-solicitation, non-interference, confidentiality and other covenants as set forth in the plan, which are applicable whether or not such benefits become available, and no benefits shall be payable unless the Company receives a waiver and release and other terms and conditions of the Change in Control Plan are satisfied.
		

		
			﻿
		

		

		

		 

 

		

			 

		

		

			Jeffrey M. Farber

		

		

			September 21, 2016

		

		

			Page 4 of 8

		

		

			 

		

		
		

		
			Other Involuntary Termination
		

		
			If (i) your employment with The Hanover is involuntarily terminated, other than in connection with your death, disability, a “Change in Control” or for “Cause” (as such terms are defined in Change in Control Plan), or (ii) you voluntarily terminate your employment for “Good Reason” (as defined below), you will be eligible to receive a cash severance payment (the “Severance Payment”) equal to 2.0 times your then current annual base salary.    Additionally, to the extent unvested, you will continue to vest in any long-term equity incentive awards for one (1) year following your termination, but in no event may vesting extend beyond the award’s expiration date in the case of stock option awards.
		

		
			﻿
		

		
			The Severance Payment will be payable in a single lump sum payment to be paid on a date that is sixty days after your termination of employment; provided that you execute and return to the Company a separation agreement that is acceptable to the Company (the “Separation Agreement”) and is irrevocable by the payment date.  The Separation Agreement will contain a full release and non-disparagement provision, along with such other terms acceptable to the Company.  
		

		
			﻿
		

		
			For purposes of this letter, the term “Good Reason” shall mean the occurrence, without your express written consent, of any of the following (i) any material and adverse change in your duties or responsibilities that result in you no longer reporting directly to the Chief Executive Officer of the Company; (ii) a reduction in your current rate of annual base salary; (iii) a reduction in your current annual short-term incentive compensation plan target award opportunity (but excluding the conversion of any cash incentive arrangement, in whole or in part, into an equity incentive arrangement of commensurate target value or vice versa); or (iv) any requirement that you relocate to an office more than 35 miles from the corporate headquarters in Worcester, MA.  Notwithstanding the foregoing with respect to subsection (iii) above, a  reduction to your target annual short-term incentive compensation opportunity of less than 10% shall not be deemed “Good Reason” if such reductions are applied to all management personnel in comparable positions at the Company. 
		

		
			﻿
		

		
			In the event you believe that a “Good Reason” event has been triggered, you must give the Company written notice within 30 days of the occurrence of such triggering event and a proposed termination date which shall be not sooner than 60 days nor later than 90 days after the date of such notice. Such notice shall specify your basis for determining that “Good Reason” has been triggered.  The Company shall have the right to cure a purported “Good Reason” within 30 days of receipt of said notice.
		

		
			﻿
		

			
	
			
				 8.
			

			
	
			
			Chaucer Board Membership:  It is anticipated that you will be elected as an Executive Director to the Chaucer board, subject to required approvals (e.g., Prudential Regulation Authority in U.K.).  In such event, you will be eligible to receive an annual Chaucer board fee (currently £20,000) paid in arrears.  Any fees associated with 2016 services will be prorated based on number of regularly scheduled meetings attended.

		
			﻿
		

		 

 

		

			 

		

		

			Jeffrey M. Farber

		

		

			September 21, 2016

		

		

			Page 5 of 8

		

		

			 

		

			
	
			
				 9.
			

			
	
			
			Covenants and Other Agreements:  The Hanover has certain conditions to employment which apply to all of its officers and senior employees.  Accordingly, as a condition of your employment with the Company, you agree that you will (i) not, directly or indirectly, during the term of your employment with The Hanover, and for a period of one year thereafter, hire, solicit, entice away or in any way interfere with The Hanover’s relationship with, any of its officers or employees, or in any way attempt to do so or participate with, assist or encourage a third party to do so; (ii) at all times, neither disclose any of The Hanover’s confidential or proprietary information to any third party, nor use such information for any purpose other than for the benefit of The Hanover and in accordance with Hanover policy; (iii) not, during the term of your employment with The Hanover, and for a period of one year thereafter, interfere with or seek to interfere with, The Hanover’s relationships with any of its policyholders, customers, clients, agents or vendors; and (iv) at all times, comply with The Hanover’s Code of Conduct and other policies and procedures as in effect from time to time. For the purposes of this provision, “confidential” or “proprietary” information shall include any information concerning the business, prospects, and goodwill of The Hanover including, by way of illustration and not limitation, all information (whether or not patentable or copyrightable) owned, possessed or used by The Hanover including, without limitation, any agent or vendor information, client information, potential agent or client lists, trade secrets, reports, technical data, computer programs, software documentation, software development, marketing or business plans, unpublished financial information, budgeting/price/cost information or agent, broker, employee or insured’s lists or compensation information, except to the extent such information is otherwise legally and publicly available.

		
			﻿
		

			
	
			
				 10.
			

			
	
			
			Representations and Other Considerations:  Please be advised that to the extent you are subject to any employment or contractual obligations to prior employer(s), the Company expects you to comply with such obligations and to inform the Company accordingly. The Hanover respects its competitors’ trade secrets and confidential information.  Please do not bring with you any confidential information or proprietary information from any of your prior employers, and please do not use such information at any time, in any way, during the course of your employment with The Hanover.

		
			﻿
		

		
			You represent that you have provided The Hanover with copies of any agreement or employment policies, including any code of conduct or similar policies, that may set forth any continuing obligations to such prior employer(s), and that you are not aware of any agreement or employment policy of any kind that will prevent you from fulfilling, or that in any way could interfere or adversely affect your ability to fulfill, your responsibilities to The Hanover in the capacities contemplated. You represent that you have no reason to believe that any regulatory authority in the U.S., United Kingdom, European Union, or elsewhere, including, but not limited to the U.S. Securities and Exchange Commission, various state departments of insurance, the U.K. Financial Conduct Authority and the U.K. Prudential Regulatory Authority, would object to you becoming an officer and director of The Hanover or of any of its insurance and non-insurance subsidiaries.  You also represent that you are not aware of any other impediment to your ability to fulfill the responsibilities contemplated as Executive Vice President, Chief Financial Officer and Principal Accounting Officer of  The Hanover or any of its subsidiaries.
		

		
			﻿
		

		 

 

		

			 

		

		

			Jeffrey M. Farber

		

		

			September 21, 2016

		

		

			Page 6 of 8

		

		

			 

		

			
	
			
				 11.
			

			
	
			
			Miscellaneous:

		
			﻿
		

		
			Electronic Payment: As a condition of employment, all employees are paid through Electronic Funds Transfer (EFT).  
		

		
			﻿
		

		
			Employment Eligibility: Under the Federal immigration law, you will be required to complete an I-9 form verifying your employment eligibility in the United States on or prior to your Employment Date.  We will provide you with a list of acceptable forms of documentation.  
		

		
			﻿
		

		
			At-Will Employment Relationship: This offer letter briefly summarizes some of the terms and conditions of your employment.  This letter is not and should not be construed as an employment contract.  Employment at The Hanover is at-will.  This means that you or the Company can terminate the employment relationship at any time, for any reason or no reason at all, with or without cause or notice.
		

		
			﻿
		

		
			Entire Agreement; Governing Law: This letter agreement sets forth the entire agreement between you and the Company and replaces all prior and contemporaneous communications, agreements and understandings, written or oral, with respect to the terms and conditions of your employment.  This letter agreement and your employment relationship shall be governed by the laws of Massachusetts, without regard to the law of conflicts.
		

		
			﻿
		

		
			Company Policies: You shall be subject to the Company’s policies as in effect from time to time, including stock ownership guidelines applicable to executive officers, Insider Trading Policy, Policy Regarding Recoupment of Formulae-Based Performance Compensation, and policies relating to hedging and pledging of securities linked to The Hanover. 
		

		
			﻿
		

		
			Withholding:  All payments made by the Company under this agreement shall be reduced by any tax or other amounts required to be withheld by the Company under applicable law.
		

		
			﻿
		

		
			Definitions: The terms the “Company” and “The Hanover” shall include, depending on the context, the direct and indirect subsidiaries of The Hanover Insurance Group, Inc.
		

		
			﻿
		

		
			Jeff, we are truly excited about your decision to join The Hanover and look forward to our future together.    
		

		
			﻿
		

		

		

		 

 

		

			 

		

		

			Jeffrey M. Farber

		

		

			September 21, 2016

		

		

			Page 7 of 8

		

		

			 

		

		
		

		
			Very truly yours,
		

		
			﻿
		

		
			/s/ Christine Bilotti-Peterson
		

		
			_________________________________
		

		
			Christine Bilotti-Peterson
		

		
			Chief Human Resources Officer 
		

		
			﻿
		

		
			﻿
		

		
			_________________________________
		

		
			﻿
		

		
			Accepted and Agreed:
		

		
			﻿
		

		
			﻿
		

		
			/s/ Jeffrey M. Farber
		

		
			______________________
		

		
			Name: Jeffrey M. Farber
		

		
			Date: September 21, 2016
		

		
			
		

		 

 

		

			 

		

		

			Jeffrey M. Farber

		

		

			September 21, 2016

		

		

			Page 8 of 8

		

		

			 

		

		Exhibit A
		

		
			﻿
		

		
			2016 Annual Short-Term 
		

		
			Incentive Compensation Plan 
		

		
			﻿
		

		
			The award payable under this program will equal the lesser of (i) 1.0% of The Hanover’s pre-tax operating income, before interest expense on debt and as adjusted to exclude the impact of catastrophes, measured over the three (3) month period ending on December 31, 2016, as reported on the Company’s financial statements as filed with the Securities and Exchange Commission on a Form 8-K (including as a cover to the year-end earnings press release) or Form 10-K;  or (ii) 50% of your 2016 annualized base salary. Provided you remain employed by the Company on the payment date, such award will be paid in March 2017 at such time as 2016 STIC awards are payable to other executives of the Company.  
		

		
			﻿EX-10.1

 Exhibit 10.1 

[EXECUTION VERSION] 
 SECOND
AMENDMENT TO CREDIT AGREEMENT 
 THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of
September 19, 2016, is entered into among AMN HEALTHCARE, INC., a Nevada corporation (the “Borrower”), AMN HEALTHCARE SERVICES, INC., a Delaware corporation (the “Parent”), the Subsidiary Guarantors
identified on the signature pages hereto, the lenders identified on the signature pages hereto (the “Lenders”) and SUNTRUST BANK, as Administrative Agent (the “Administrative Agent”). 

W I T N E S S E T H 

WHEREAS, the Borrower, the Parent, the Subsidiary Guarantors, the Lenders party thereto, the Administrative Agent and the Syndication
Agent (as defined therein) have entered into that certain Credit Agreement dated as of April 18, 2014, as amended by that certain First Amendment to Credit Agreement dated as of January 4, 2016 (the “Existing Credit Agreement”);

 WHEREAS, the Credit Parties have requested that the Lenders amend the Existing Credit Agreement as provided herein;

WHEREAS, the Requisite Lenders have agreed to amend the Existing Credit Agreement on the terms and conditions hereinafter set forth.

 NOW, THEREFORE, in consideration of the agreements hereinafter set forth, and for other good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows: 
 PART 1 

DEFINITIONS 
 SUBPART
1.1 Certain Definitions. Unless otherwise defined herein or the context otherwise requires, the following terms used in this Amendment, including its preamble and recitals, have the following meanings: 

“Amended Credit Agreement” means the Existing Credit Agreement as amended hereby. 

“Second Amendment” has the meaning set forth in Part 3. 

SUBPART 1.2 Other Definitions. Unless otherwise defined herein or the context otherwise requires, terms used in
this Amendment, including its preamble and recitals, have the meanings provided in the Existing Credit Agreement. 
 PART 2 

AMENDMENTS TO EXISTING CREDIT AGREEMENT 

Effective on (and subject to the occurrence of) the Second Amendment Effective Date, the Existing Credit Agreement is hereby amended as
follows: 
 SUBPART 2.1 New Definitions. The following definitions are hereby
added to Section 1.1 of the Credit Agreement in the appropriate alphabetical order: 

 “Fixed Incremental Amount” shall mean, at any time, an amount
equal to (x) $125,000,000 less (y) the aggregate principal amount of all increases in the Revolving Committed Amount pursuant to Section 2.7 and all Incremental Term Loans, pursuant to Section 2.6, in each case, previously incurred or issued in
reliance on the Fixed Incremental Amount. 
 “Incremental Cap” shall mean (a) the Fixed Incremental Amount
plus (b) the aggregate amount of any voluntary prepayment of Term Loans and/or any permanent reductions of the commitments under any Revolving Facility. 

SUBPART 2.2 Amendments to Section 2.6. Clause (i) of Section 2.6(a) of the Existing Credit Agreement is hereby
amended and restated in its entirety to read as follows: 
 (i) the aggregate original principal amount of all Incremental
Term Loans made pursuant to this Section 2.6 and the aggregate amount of all increases in the Revolving Committed Amount made pursuant to Section 2.7, in each case following the First Amendment
Effective Date, shall not, in the aggregate, exceed the Incremental Cap at the time such Incremental Term Loans are established.

SUBPART 2.3 Amendment to Section 2.7. Clause (a) of Section 2.7 of the Existing Credit Agreement is hereby
amended and restated in its entirety to read as follows: 
 (a) the aggregate original principal amount of all Incremental
Term Loans made pursuant to Section 2.6 and the aggregate amount of all increases in the Revolving Committed Amount made pursuant to this Section 2.7, in each case following the First Amendment
Effective Date, shall not, in the aggregate, exceed the Incremental Cap at the time such increase in the Revolving Committed Amount is established.

SUBPART 2.4 Amendment to Section 8.1. Clause (g)(iv) of Section 8.1 of the Existing Credit Agreement is hereby
amended and restated in its entirety to read as follows: 
 (iv) such Indebtedness shall not be required to be repaid,
prepaid, redeemed, repurchased or defeased, whether on one or more fixed dates, upon the occurrence of one or more events or at the option of any holder thereof prior to the latest Maturity Date in effect at the time of incurrence of such
Indebtedness; provided that it is understood and agreed that a customary mandatory offer to purchase notes as a result of a change of control or sale of assets provision in a note indenture shall not violate this clause (g)(iv);

PART 3 
 CONDITIONS TO
EFFECTIVENESS 
 SUBPART 3.1 Second Amendment Effective Date. This Amendment shall be and become
effective as of the date hereof (the “Second Amendment Effective Date”) when all of the conditions set forth in this Part 3 shall have been satisfied, and thereafter this Amendment shall be known, and may be referred to, as
the “Second Amendment”. 
 SUBPART 3.2 Execution of Counterparts of Amendment. The
Administrative Agent shall have received counterparts of this Amendment, which collectively shall have been duly executed on behalf of each of the Borrower, the Parent, the Subsidiary Guarantors, the Requisite Lenders and the Administrative Agent.

  
 2 

 SUBPART 3.3 Fees and Expenses. The Administrative Agent or one of its
affiliates shall have received from the Borrower all reasonable and documented out-of-pocket costs and expenses of the Administrative Agent in connection with the preparation, execution and delivery of this Amendment, including without limitation
the reasonable fees and expenses of Moore & Van Allen PLLC, counsel to the Administrative Agent. 
 PART 4 

MISCELLANEOUS 
 SUBPART
4.1 Representations and Warranties. The Borrower hereby represents and warrants to the Administrative Agent and the Lenders that, (a) no Default or Event of Default exists under the Existing Credit Agreement, both before
and after giving effect to this Amendment and (b) the representations and warranties set forth in Section 6 of the Amended Credit Agreement are, subject to the limitations set forth therein, true and correct in all material respects (except to the
extent that any representation and warranty is qualified by materiality, in which case such representation and warranty shall be true and correct in all respects) as of the date hereof (except for those which expressly relate to an earlier date, in
which case, they were true and correct in all material respects as of such earlier date). 
 SUBPART
4.2 Cross-References. References in this Amendment to any Part or Subpart are, unless otherwise specified, to such Part or Subpart of this Amendment. 

SUBPART 4.3 Instrument Pursuant to Existing Credit Agreement. This Amendment is executed pursuant to the
Existing Credit Agreement and shall (unless otherwise expressly indicated therein) be construed, administered and applied in accordance with the terms and provisions of the Existing Credit Agreement. 

SUBPART 4.4 References in Other Credit Documents. At such time as this Amendment shall become effective
pursuant to the terms of Subpart 3.1, all references to the “Credit Agreement” shall be deemed to refer to the Amended Credit Agreement. 

SUBPART 4.5 Counterparts. This Amendment may be executed by the parties hereto in several counterparts, each of
which shall be deemed to be an original and all of which shall constitute together but one and the same agreement. Delivery of executed counterparts of the Amendment by facsimile or other electronic transmission shall be effective as an
original and shall constitute a representation that an original shall be delivered upon the request of the Administrative Agent. 

SUBPART 4.6 Governing Law. THIS AMENDMENT SHALL BE DEEMED TO BE A CONTRACT MADE UNDER AND GOVERNED BY THE LAWS
OF THE STATE OF NEW YORK. 
 SUBPART 4.7 Acknowledgment. The Guarantors acknowledge and consent to all of the
terms and conditions of this Amendment and agree that this Amendment does not operate to reduce or discharge the Guarantors’ obligations under the Amended Credit Agreement or the other Credit Documents. The Guarantors further acknowledge
and agree that the Guarantors have no claims, counterclaims, offsets, or defenses to the Credit Documents and the performance of the Guarantors’ obligations thereunder or if the Guarantors did have any such claims, counterclaims, offsets or
defenses to the Credit Documents or any transaction related to the Credit Documents, the same are hereby waived, relinquished and released in consideration of the Lenders’ execution and delivery of this Amendment. Each Guarantor also
hereby confirms and agrees that notwithstanding the effectiveness of this Amendment, the Collateral Documents to which each of the undersigned is a party and all of the Collateral described therein do, and shall continue to, secure the payment of
all of the Credit Party Obligations. 
 SUBPART 4.8 Binding Effect. This Amendment, the Existing Credit
Agreement as amended by 

  
 3 

 
this Amendment and the other Credit Documents embody the entire agreement between the parties and supersede all prior agreements and understandings, if any, relating to the subject matter
hereof. These Credit Documents represent the final agreement between the parties and may not be contradicted by evidence of prior, contemporaneous or subsequent oral agreements of the parties. Except as expressly modified and amended in
this Amendment, all the terms, provisions and conditions of the Credit Documents shall remain unchanged and shall continue in full force and effect. 

SUBPART 4.9 Successors and Assigns. This Amendment shall be binding upon and inure to the benefit of the
parties hereto and their respective successors and assigns. 
 SUBPART 4.10 General. Except as amended
hereby, the Existing Credit Agreement and all other credit documents shall continue in full force and effect. 
 SUBPART 4.11
Severability. If any provision of this Amendment is determined to be illegal, invalid or unenforceable, such provision shall be fully severable and the remaining provisions shall remain in full force and effect and shall be construed
without giving effect to the illegal, invalid or unenforceable provisions. 
 SUBPART 4.12 Ratification. Each Credit
Party acknowledges and consents to the terms set forth herein and agrees that this Amendment does not impair, reduce or limit any of its obligations under the Credit Documents, as amended hereby, and that each of the Credit Documents, as amended
hereby, is ratified and confirmed in all respects. This Agreement is a Credit Document. 
 [Remainder of Page Intentionally Left Blank]

  
 4 

 [EXECUTION VERSION] 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written. 

 

							
	BORROWER:	 		 	AMN HEALTHCARE, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
	PARENT:	 		 	AMN HEALTHCARE SERVICES, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
	SUBSIDIARY	 		 	
	GUARANTORS:	 		 	AMN SERVICES, LLC
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	O’GRADY-PEYTON INTERNATIONAL (USA), INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	AMN STAFFING SERVICES, LLC
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	MERRITT, HAWKINS & ASSOCIATES, LLC
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	AMN HEALTHCARE ALLIED, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer

							
		 		 	STAFF CARE, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	AMN ALLIED SERVICES, LLC
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	NURSEFINDERS, LLC
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	RX PRO HEALTH, LLC
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	LINDE HEALTH CARE STAFFING, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	SHIFTWISE, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	THE FIRST STRING HEALTHCARE, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	MILLICANSOLUTIONS, LLC
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer

  
 2 

							
		 		 	AVANTAS, LLC
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	ONWARD HEALTHCARE, LLC
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	LOCUM LEADERS, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	MEDEFIS, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	HEALTHSOURCE GLOBAL STAFFING, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	PEAK HEALTH SOLUTIONS, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	PEAK GOVERNMENT SERVICES, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	PEAK PROVIDER SOLUTIONS, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	B.E. SMITH INTERIM SERVICES, INC.

  
 3 

							
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	B.E. SMITH INTERNATIONAL, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	B.E. SMITH, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer
			
		 		 	JOSEM HOLDING, INC.
				
		 		 	By:	 	 /s/ Brian Scott

		 		 	Name:	 	Brian Scott
		 		 	Title:	 	Chief Financial Officer

  
 4 

							
	ADMINISTRATIVE AGENT:	 		 	SUNTRUST BANK,
		 		 	in its capacity as Administrative Agent
				
		 		 	By:	 	 /s/ Jared Cohen

		 		 	Name:	 	Jared Cohen
		 		 	Title:	 	Vice President
			
	LENDERS:	 		 	SUNTRUST BANK,
		 		 	in its capacity as Lender, Issuing Lender and Swingline Lender
				
		 		 	By:	 	 /s/ Jared Cohen

		 		 	Name:	 	Jared Cohen
		 		 	Title:	 	Vice President

  
 5 

							
		 		 	Wells Fargo Bank, N.A, as a Lender
				
		 		 	By:	 	 /s/ Darin Mullis

		 		 	Name:	 	Darin Mullis
		 		 	Title:	 	Director

  
 6 

							
		 		 	KeyBank National Association, as a Lender
				
		 		 	By:	 	 /s/ Thomas A. Crandell

		 		 	Name:	 	Thomas A. Crandell
		 		 	Title:	 	Senior Vice President

							
		 		 	Bank of America, N.A., as a Lender
				
		 		 	By:	 	 /s/ Heath Lipson

		 		 	Name:	 	Heath Lipson
		 		 	Title:	 	Senior Vice President

							
		 		 	COMERICA BANK, as a Lender
				
		 		 	By:	 	 /s/ Liz V Gonzalez

		 		 	Name:	 	Liz V Gonzalez
		 		 	Title:	 	Assistant Vice President & Relationship Manager

							
		 		 	JPMorgan Chase Bank, N.A., as a Lender
				
		 		 	By:	 	 /s/ Anna C. Araya

		 		 	Name:	 	Anna C. Araya
		 		 	Title:	 	Executive Director

							
		 		 	MANUFACTURERS BANK, as a Lender
				
		 		 	By:	 	 /s/ Sandy Lee

		 		 	Name:	 	Sandy Lee
		 		 	Title:	 	Vice President

							
		 		 	The Bank of Tokyo-Mitsubishi UFJ, Ltd., as a Lender
				
		 		 	By:	 	 /s/ Teuta Ghilaga

		 		 	Name:	 	Teuta Ghilaga
		 		 	Title:	 	Director

							
		 		 	Compass Bank, as a Lender
				
		 		 	By:	 	 /s/ James Ligman

		 		 	Name:	 	James Ligman
		 		 	Title:	 	SVP

							
		 		 	Fifth Third Bank, as a Lender
				
		 		 	By:	 	 /s/ Thomas Avery

		 		 	Name:	 	Thomas Avery
		 		 	Title:	 	Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}]]